CN102552656B - 一种用于治疗鸡大肠杆菌病的中药组合物 - Google Patents
一种用于治疗鸡大肠杆菌病的中药组合物 Download PDFInfo
- Publication number
- CN102552656B CN102552656B CN201210016598.4A CN201210016598A CN102552656B CN 102552656 B CN102552656 B CN 102552656B CN 201210016598 A CN201210016598 A CN 201210016598A CN 102552656 B CN102552656 B CN 102552656B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- chinese medicine
- radix
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 130
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 94
- 238000011282 treatment Methods 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 26
- 239000008367 deionised water Substances 0.000 claims description 19
- 229910021641 deionized water Inorganic materials 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 17
- 241000756943 Codonopsis Species 0.000 claims description 15
- 239000008589 Cortex Fraxini Substances 0.000 claims description 15
- 239000000469 ethanolic extract Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 12
- 210000003038 endothelium Anatomy 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 10
- 239000003463 adsorbent Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 46
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 41
- 201000010099 disease Diseases 0.000 abstract description 38
- 230000001717 pathogenic effect Effects 0.000 abstract description 29
- 238000005728 strengthening Methods 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 244000025596 Cassia laevigata Species 0.000 abstract 1
- 235000006693 Cassia laevigata Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000233952 Polygonum bistorta Species 0.000 abstract 1
- 235000014258 Polygonum bistorta Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241001534869 Terminalia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940124513 senna glycoside Drugs 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 description 82
- 239000008280 blood Substances 0.000 description 39
- 210000004369 blood Anatomy 0.000 description 37
- 210000000952 spleen Anatomy 0.000 description 34
- 208000001848 dysentery Diseases 0.000 description 26
- 210000002784 stomach Anatomy 0.000 description 26
- 238000012360 testing method Methods 0.000 description 26
- 208000024891 symptom Diseases 0.000 description 25
- 210000004072 lung Anatomy 0.000 description 24
- 210000004185 liver Anatomy 0.000 description 21
- 231100000614 poison Toxicity 0.000 description 21
- 241000588724 Escherichia coli Species 0.000 description 19
- 239000003440 toxic substance Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 210000002429 large intestine Anatomy 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 230000036528 appetite Effects 0.000 description 9
- 235000019789 appetite Nutrition 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- 239000002158 endotoxin Substances 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 description 7
- 206010059866 Drug resistance Diseases 0.000 description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 7
- 241000194017 Streptococcus Species 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 208000019790 abdominal distention Diseases 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 229960000740 enrofloxacin Drugs 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 208000008494 pericarditis Diseases 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 206010071301 Perihepatitis Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000003014 reinforcing effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000008485 antagonism Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000003746 feather Anatomy 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010024264 Lethargy Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 3
- 229960004306 sulfadiazine Drugs 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 239000004258 Ethoxyquin Substances 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010057071 Rectal tenesmus Diseases 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 2
- 229940093500 ethoxyquin Drugs 0.000 description 2
- 235000019285 ethoxyquin Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 206010034674 peritonitis Diseases 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000012271 tenesmus Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000003606 umbilical vein Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061126 Escherichia infection Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000020612 escherichia coli infection Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 206010030306 omphalitis Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Abstract
Description
分组 | 总数 | 发病(只) | 死亡(只) | 死亡率(%) |
1(79mg/只) | 10 | 0 | 0 | 0 |
2(127.1mg/只) | 10 | 0 | 0 | 0 |
3(213.9mg/只) | 10 | 0 | 0 | 0 |
4(300.6mg/只) | 10 | 0 | 0 | 0 |
对照组 | 10 | 0 | 0 | 0 |
分组 | 鸡只 | 处理 |
组1:低剂量组口服液1 | 100 | 感染,1g/mL饮用,2次/天 |
组2:高剂量组口服液1 | 100 | 感染,2g/mL饮用,2次/天 |
组3:恩诺沙星对照组 | 100 | 感染,2 mg/mL饮用,2次/天 |
组4:感染对照组 | 100 | 感染,不给药 |
组5:空白对照组 | 100 | 不感染,不给药 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210016598.4A CN102552656B (zh) | 2012-01-19 | 2012-01-19 | 一种用于治疗鸡大肠杆菌病的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210016598.4A CN102552656B (zh) | 2012-01-19 | 2012-01-19 | 一种用于治疗鸡大肠杆菌病的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552656A CN102552656A (zh) | 2012-07-11 |
CN102552656B true CN102552656B (zh) | 2014-04-09 |
Family
ID=46400110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210016598.4A Active CN102552656B (zh) | 2012-01-19 | 2012-01-19 | 一种用于治疗鸡大肠杆菌病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552656B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103416616B (zh) * | 2013-07-25 | 2014-07-09 | 江苏农林职业技术学院 | 一种含有中药添加剂的肉鸡颗粒饲料及其制备方法 |
CN103977058B (zh) * | 2014-05-26 | 2017-03-29 | 山东省农业科学院家禽研究所 | 一种防治鸡大肠杆菌病的中草药口服液及生产工艺 |
CN104147165A (zh) * | 2014-08-13 | 2014-11-19 | 韦旭斌 | 一种防治动物大肠杆菌病的中药及制备方法 |
CN104306881A (zh) * | 2014-10-10 | 2015-01-28 | 天津瑞贝特科技发展有限公司 | 防治家禽大肠杆菌疾病的注射液及其制备方法 |
CN105477312B (zh) * | 2015-12-25 | 2019-03-08 | 石家庄市九洲兽药有限公司 | 治疗鸡大肠杆菌病的中药组合物 |
CN115281146B (zh) * | 2022-07-08 | 2023-06-16 | 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) | 一种鸡湿热下利证模型的构建方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101785844A (zh) * | 2010-02-28 | 2010-07-28 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗痢疾的中药组合物及其制备方法 |
CN101972392A (zh) * | 2010-08-25 | 2011-02-16 | 天津生机集团股份有限公司 | 治疗鸡大肠杆菌病的中药组合物及其制备方法 |
CN102670896A (zh) * | 2012-05-07 | 2012-09-19 | 成都绿迪科技有限公司 | 一种治疗细菌性痢疾的中成药 |
-
2012
- 2012-01-19 CN CN201210016598.4A patent/CN102552656B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101785844A (zh) * | 2010-02-28 | 2010-07-28 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗痢疾的中药组合物及其制备方法 |
CN101972392A (zh) * | 2010-08-25 | 2011-02-16 | 天津生机集团股份有限公司 | 治疗鸡大肠杆菌病的中药组合物及其制备方法 |
CN102670896A (zh) * | 2012-05-07 | 2012-09-19 | 成都绿迪科技有限公司 | 一种治疗细菌性痢疾的中成药 |
Non-Patent Citations (4)
Title |
---|
中兽医学免疫(续);刘娟等;《中兽医医药杂志》;20030830(第04期);44-45,参见第44页右栏第6段 * |
中草药添加剂在养禽生产中的应用;黄中利等;《山东家禽》;20030330(第03期);49-53,第49页左栏第4段,第50页左栏第2段,右栏第3段 * |
刘娟等.中兽医学免疫(续).《中兽医医药杂志》.2003,(第04期),44-45,参见第44页右栏第6段. |
黄中利等.中草药添加剂在养禽生产中的应用.《山东家禽》.2003,(第03期),49-53,第49页左栏第4段,第50页左栏第2段,右栏第3段. |
Also Published As
Publication number | Publication date |
---|---|
CN102552656A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102835609B (zh) | 具有防止仔猪腹泻作用的猪饲料和中药组合物 | |
CN102698123B (zh) | 治疗猪传染性胃肠炎的中药组合物、饲料、制备和应用 | |
CN104012798B (zh) | 用于治疗母猪子宫内膜炎的饲料、中药组合物及制备方法 | |
CN104256168B (zh) | 一种猪功能性饲料及其制备方法 | |
CN102552656B (zh) | 一种用于治疗鸡大肠杆菌病的中药组合物 | |
CN104187172B (zh) | 用于治疗乌龟肠胃炎病的功能性饲料及其制备方法 | |
CN103495091B (zh) | 用于预防柔嫩艾美尔球虫感染的中药免疫制剂 | |
CN102698088B (zh) | 治疗鸡新城疫的中药组合物、饲料、制备方法和应用 | |
CN103719609B (zh) | 一种哺乳期母猪饲料及其制备方法 | |
CN104256096A (zh) | 用于治疗仔猪痢疾的饲料添加剂及饲料 | |
CN102716297B (zh) | 一种治疗疫毒型牛痢疾的中药组合物及应用 | |
CN103585578A (zh) | 一种防治肉鸡大肠杆菌病的中药 | |
CN102526510B (zh) | 一种用于预防和治疗鸭病毒性肝炎的中药组合物 | |
CN104543576B (zh) | 防治仔猪腹泻的复合植物提取物饲料添加剂及其制法应用 | |
CN104258139A (zh) | 一种用于防治慢性型猪瘟疫的药物组合物及其制备方法 | |
CN103721103A (zh) | 用于治疗猪丹毒的药物及其制备方法 | |
CN103202908B (zh) | 预防和治疗大肠杆菌病的中草药饲料添加剂 | |
CN106421176A (zh) | 防治断奶仔猪腹泻的中药散剂 | |
CN106511675A (zh) | 一种用于防治家禽疾病的药及其制备方法 | |
CN103652490B (zh) | 用于治疗猪蓝耳病的猪饲料及其制备方法 | |
CN102872321A (zh) | 一种防治猪蓝耳病的中药制剂及其制备方法 | |
CN104547186A (zh) | 用于预防、治疗禽霍乱的复方发酵型中药及其制备方法 | |
CN105250972A (zh) | 一种防治家禽腺胃炎的中药组合物及其制备方法和用途 | |
CN102552657B (zh) | 一种用于治疗鸡新城疫病的中药组合物 | |
CN104547770A (zh) | 一种促进畜禽生长的发酵中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 266061 Shandong city of Qingdao province Chengyang Qingda Industrial Park, the first northbound dual Applicant after: QINGDAO VLAND BIOLOGICAL CO., LTD. Applicant after: Heze Puen Pharmaceutical Co., Ltd. Address before: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Applicant before: Qingdao KDN Pharmaceutical Co., Ltd. Applicant before: Heze Puen Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: QINGDAO KDN PHARMACEUTICAL CO., LTD. TO: QINGDAO WEILAN BIOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170215 Address after: 266109 Shandong city of Qingdao province high tech Zone Songyuan Road No. 17 Qingdao City Industrial Research Institute C1 District 307 Patentee after: Qingdao National Engineering Technology Research Center Co., Ltd. Patentee after: QINGDAO VLAND BIOLOGICAL CO., LTD. Patentee after: Heze Puen Pharmaceutical Co., Ltd. Address before: 266061 Shandong city of Qingdao province Chengyang Qingda Industrial Park, the first northbound dual Patentee before: QINGDAO VLAND BIOLOGICAL CO., LTD. Patentee before: Heze Puen Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220616 Address after: 266000 No.3 Chunhai Road, Qingda Industrial Park, Chengyang District, Qingdao City, Shandong Province Patentee after: QINGDAO ANIMAL PROTECTION NATIONAL ENGINEERING TECHNOLOGY RESEARCH CENTER CO.,LTD. Patentee after: Qingdao Yulan biological Co., Ltd Address before: Room 307, zone C1, Qingdao Industrial Research Institute, No.17, Songyuan Road, high tech Zone, Qingdao, Shandong 266109 Patentee before: QINGDAO ANIMAL PROTECTION NATIONAL ENGINEERING TECHNOLOGY RESEARCH CENTER CO.,LTD. Patentee before: QINGDAO VLAND BIOTECH Inc. Patentee before: HEZE PUEN PHARMACEUTICAL Co.,Ltd. |